Exercise and Glucose Production in Type 2 Diabetes and Fatty Liver
This study is looking at how exercise affects the amount of sugar (glucose) your liver makes, especially in people with Type 2 Diabetes (T2D) and fatty liver (hepatic steatosis). Researchers will use Magnetic Resonance Liver Assessment to measure liver fat, Bike Exercise VO2max to check fitness, and DEXA to measure body composition. The main goal is to measure your body's own glucose production after 14 days. You may be able to join if you are between 25 and 55 years old, have Type 2 Diabetes, and have at least 5.6% liver fat. The current recruitment status is unclear.
- Study design
- This is an interventional study with a planned enrollment of 12 participants. The phase of the study is not specified.
- What's involved
- You would need to agree to all study procedures and be available for the entire study duration. This includes measurements like liver fat assessment, fitness testing, and body composition scans.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, measurement of Endogenous Glucose Production (EGP), is taken at Day 14. Further follow-up is not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Justine Mucinski, PhD · PRINCIPAL_INVESTIGATOR · AdventHealth
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Measurement of Endogenous Glucose Production (EGP)Day 14
Bulk EGP will be measured during resting and exercise conditions to determine how Endogenous Glucose Production (EGP) differs during exercise (compared to no exercise) in T2D and Metabolic dysfunction associated steatotic liver disease (MASLD).